MedPath

Comparison of 1- day and 2-days prophylactic antimicrobial administration for inhibiting surgical site infection (SSI) in Holmium Laser Enucleation of the prostate (HoLEP).

Not Applicable
Conditions
Benign prostate hyperplasia
Registration Number
JPRN-UMIN000027955
Lead Sponsor
Kobe Univerity
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete: follow-up complete
Sex
Male
Target Recruitment
400
Inclusion Criteria

Not provided

Exclusion Criteria

Those patients who do not agree with this study as a participant.

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Rate of SSI occurence
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath